This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

Out of public health concerns and given the current travel restrictions and lab closures worldwide because of COVID-19, the 27th International Symposium on Hepatitis C Virus and Related Viruses (HCV2020), scheduled to take place July 6 – 9, 2020 in Montreal, Canada has been postponed to July 6 - 9, 2021 and will now be delivered Virtually.



Sonya MacParland

Assistant Professor
University of Toronto/ University Health Network

Dr. Sonya MacParland, PhD, is a University Health Network Scientist in the Toronto General Hospital’s Soham & Shaila Ajmera Family Transplant Centre and an Assistant Professor in the University of Toronto’s department of Laboratory Medicine and Pathobiology and the department of Immunology. Dr. MacParland trained with Dr. Thomas Michalak (Memorial University of Newfoundland) and Dr. Mario Ostrowski (University of Toronto) as part of the CanHepC program.

Dr. MacParland's research program is focused on translating fundamental knowledge about the immune biology of the liver into clinical applications. Dr. MacParland and her research team are using advanced genomics including single cell RNA sequencing to describe the microenvironment of the healthy and diseased human liver. Her team recently developed the first transcriptomic map of the human liver (Nature Communications; 2018) as a platform to examine how immune dysregulation drives liver diseases. Her team is also examining how the liver immune environment can be therapeutically targeted and manipulated using nanoparticles to slow or reverse ongoing damage (Nature Materials; 2016, ACS Nano; 2017).